SCHEMBL6641968

SCHEMBL6641968

O=C1Nc2ccc([N+](=O)[O-])cc2C2CCCC12

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOS3 P29474 2/20 0.51
NOS1 P29475 2/20 0.51
NOS2 P35228 2/20 0.51
PGR P06401 1/20 0.46
ALDH1A1 P00352 5/20 0.44
GAA P10253 1/20 0.44
HSP90AA1 P07900 1/20 0.43
CAPN9 O14815 1/20 0.43
CASP3 P42574 1/20 0.43
EIF2AK2 P19525 1/20 0.43
ABCC8 Q09428 1/20 0.43
KCNJ11 Q14654 1/20 0.43
CHRNB4 P30926 2/20 0.41
CHRNA3 P32297 2/20 0.41
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
CYP3A4 P08684 2/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
TDP1 Q9NUW8 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6643026 0.89 NOS3 (0.51) NOS3NOS1NOS2PGRALDH1A1
SCHEMBL6643304 0.84 NOS3 (0.50) NOS3NOS1NOS2PGRALDH1A1
SCHEMBL6644155 0.81 LMNA (0.43) NOS3NOS1NOS2PGRALDH1A1
SCHEMBL11427314 0.76 PGR (0.72) PGRALDH1A1GAACAPN9CASP3
SCHEMBL6640591 0.76 NOS3 (0.44) NOS3NOS1NOS2ABCC8KCNJ11
SCHEMBL6137367 0.76 SIRT2 (0.50) NOS3NOS1NOS2PGRABCC8
SCHEMBL6069995 0.76 NOS3 (0.45) NOS3NOS1NOS2ALDH1A1CYP3A4
SCHEMBL6645803 0.76 NOS3 (0.44) NOS3NOS1NOS2ALDH1A1MEN1
SCHEMBL6643002 0.75 MAPK1 (0.38) NOS3NOS1NOS2ALDH1A1GAA
SCHEMBL6646342 0.73 NOS3 (0.50) NOS3NOS1NOS2GAAHSP90AA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1054869-B1 3,4-DIHYDROQUINOLINE DERIVATIVES AS NITROGEN MONOXIDE SYNTHASE (NOS) INHIBITORS SCHERING AG (DE) 2004-09-22 EP disclosed
US-6391887-B1 ANTIINFLAMMATORY AGENTS; AUTOIMMUNE DISEASE; CARDIOVASCULAR DISORDERS SCHERING AKTIENGESELLSCHAFT (DE) 2002-05-21 US disclosed